DOC: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Cash Flow Overview

No enough data to generate the overview

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Net income (loss)	-20,765	89,083	50,064	256,631
Depreciation and amortization of real estate, in-place lease, and other intangibles	796,779	534,462	268,546	782,736
Stock-based compensation amortization expense	10,410	6,365	4,627	11,935
Merger-related post-combination stock compensation expense	0	0	0	16,223
Amortization of deferred financing costs and debt discounts (premiums)	23,708	15,727	7,852	19,247
Straight-line rents	30,836	16,554	11,153	32,891
Amortization of non-refundable entrance fees and above (below) market lease intangibles	-100,215	-67,954	-34,218	-88,925
Equity loss (income) from unconsolidated joint ventures	-176,691	-400	-2,147	-1,407
Distributions of earnings from unconsolidated joint ventures	16,861	9,720	7,094	11,228
Deferred income tax expense (benefit)	-131	2,068	946	11,156
Impairments and loan loss reserves (recoveries), net	-117	-63	-3,562	11,346
Loss (gain) on sales of real estate, net	13,136	1,636	0	187,624
Loss (gain) upon change of control, net	0	0	0	77,548
Casualty-related loss (recoveries), net	-9,825	-11,308	-6,249	574
Other non-cash items	7,826	5,214	2,658	1,652
Decrease (increase) in accounts receivable and other assets, net	-9,756	-30,883	-7,212	-2,071
Increase (decrease) in accounts payable, accrued liabilities, and deferred revenue	86,871	34,319	-23,717	52,200
Net cash provided by (used in) operating activities	957,875	642,914	279,429	786,966
Acquisitions of real estate	43,880	37,533	37,533	4,466
Development, redevelopment, and other major improvements of real estate	547,087	324,372	166,040	399,373
Leasing costs, tenant improvements, and recurring capital expenditures	76,125	48,864	23,136	76,744
Proceeds from sales of real estate, net	30,839	5,089	0	619,981
Proceeds from the callan ridge jv transaction, net	0	0	0	125,662
Investments in unconsolidated joint ventures	76,329	53,907	32,434	54,450
Distributions in excess of earnings from unconsolidated joint ventures	22,745	15,548	7,478	20,195
Proceeds from insurance recovery	12,214	1,676	386	6,467
Proceeds from sales/principal repayments on loans receivable and other	125,927	67,287	64,141	87,259
Investments in loans receivable and other	77,357	65,897	43,576	25,341
Cash paid in connection with the merger, net	0	0	0	-179,215
Net cash provided by (used in) investing activities	-629,053	-440,973	-230,714	119,975
Borrowings under bank line of credit and commercial paper	9,435,650	6,733,650	4,279,000	3,146,250
Repayments under bank line of credit and commercial paper	9,217,525	6,108,650	4,265,000	3,866,250
Issuances and borrowings of term loans, senior unsecured notes, and mortgage debt	987,260	494,495	494,495	750,000
Repayments and repurchases of term loans, senior unsecured notes, and mortgage debt	806,492	805,576	352,864	3,038
Payments for deferred financing costs	2,604	1,471	1,471	5,438
Issuance of common stock and exercise of options, net of offering costs	304	171	64	241
Repurchase of common stock	97,058	97,041	24,959	190,364
Dividends paid on common stock	637,234	425,360	213,479	584,964
Distributions to and purchase of noncontrolling interests	28,820	19,155	10,200	80,368
Contributions from and issuance of noncontrolling interests	13,124	5,970	0	12
Net cash provided by (used in) financing activities	-353,395	-222,967	-94,414	-833,919
Net increase (decrease) in cash, cash equivalents, and restricted cash	-24,573	-21,026	-45,699	73,022
Cash and cash equivalents at beginning of period	184,305	184,305	184,305	169,023
Cash and cash equivalents at end of period	159,732	163,279	138,606	242,045

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

DOC: the cashflow